NCT04051736View on ClinicalTrials.gov

Immunogenicity and Safety of Sabin-IPV Replacement Vaccination

PHASE4CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

December 28, 2018

Study Completion Date

August 31, 2020

Conditions
Vaccination
Interventions
BIOLOGICAL

Inactivated Polio Vaccine

Inactivated Polio Vaccine at age of 2,3,4 months old, respectively

Trial Locations (1)

100013

Beijing Center for Disease Control and Prevention, Beijing

All Listed Sponsors
collaborator

Beijing Institute of Biological Products Co Ltd.

INDUSTRY

collaborator

Beijing Center for Disease Control and Prevention

OTHER_GOV

collaborator

Peking University

OTHER

lead

China National Biotec Group Company Limited

INDUSTRY

NCT04051736 - Immunogenicity and Safety of Sabin-IPV Replacement Vaccination | Biotech Hunter | Biotech Hunter